CAH
Cardinal Health, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Last price
229.26
▲ 0.80 (0.35%)
MARKET · —
Price
Open
228.46
Prev close
228.46
Day high
231.26
Day low
228.23
Volume
926.88K
Market cap
$53.38B
P/E (TTM)
31.66
52W range
145.87 – 258.30
Trailing performance
Returnvs SPY
1W
-2.41%
-1.0%
1M
+1.56%
-2.2%
3M
+14.41%
+11.3%
6M
+2.26%
-8.8%
YTD
+11.68%
-0.6%
1Y
+50.06%
+30.1%
3Y
+153.88%
+79.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$53.38B
Enterprise value$58.68B
Revenue (TTM)$254.25B
Gross profit$9.77B
EBITDA$4.24B
Net income$1.71B
EPS (TTM)$7.25
Free cash flow$4.75B
Total cash$4.86B
Total debt$10.00B
Book value / share$-12.37
Shares outstanding232.58M
Float231.84M
Short % of float3.27%
Dividend yield0.90%
Beta (5Y)0.52
Valuation & profitability ratios
Trailing P/E31.66
Forward P/E16.31
PEG ratio1.20
Price / sales—
Price / book—
EV / revenue0.23
EV / EBITDA13.83
Gross margin3.84%
Operating margin1.33%
Profit margin0.67%
Return on equity—
Return on assets3.72%
Debt / equity—
Current ratio0.88
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Total revenue | $254.25B | $222.58B | $226.83B | $205.01B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $1.71B | $1.56B | $852.00M | $261.00M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net income | $1.71B | $1.56B | $852.00M | $261.00M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 2.42 | 2.60 | +7.4% |
| Mar 2026 | 2.79 | 3.17 | +13.7% |
| Dec 2025 | 1.92 | 1.97 | +2.6% |
| Sep 2025 | 2.17 | 2.55 | +17.6% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 2.94 | 15 | $66.67B | +4.2% |
| Next quarter | 3.11 | 14 | $68.27B | +4.0% |
| Current year | 10.23 | 5 | $265.72B | +4.5% |
| Next year | 14.07 | 17 | $281.80B | +6.1% |
Analyst targets & ownership
Mean target$270.94
High target$292.00
Low target$235.00
Implied upside18.18%
Analyst count16
ConsensusSTRONG BUY
Strong buy / Buy3 / 12
Hold3
Sell / Strong sell0 / 0
Held by insiders0.27%
Held by institutions90.92%
Institutions holding1.98K
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+259.61K
Net buying
Buy transactions
17
482.89K shares
Sell transactions
6
223.28K shares
Net transactions
+23
Buys less sells
Sell : buy shares
0.5 : 1
Mixed
Insider-held shares
620.98K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 19, 26 | HOLLAR JASON M Chief Executive Officer |
SELL | 124.53K | $29.38M | Direct |
| Aug 18, 26 | ALT AARON E. Chief Financial Officer |
SELL | 42.00K | $9.93M | Direct |
| Aug 18, 26 | MASON STEPHEN M Officer |
SELL | 35.00K | $8.27M | Direct |
| Aug 18, 26 | GREENE MICHELLE D Chief Technology Officer |
SELL | 11.65K | $2.75M | Direct |
| Aug 18, 26 | WEITZMAN DEBORAH Officer |
SELL | 7.35K | $1.73M | Direct |
| Aug 14, 26 | ALT AARON E. Chief Financial Officer |
STOCK | 8.08K | $0 | Direct |
| Aug 14, 26 | HOLLAR JASON M Chief Executive Officer |
STOCK | 30.62K | $0 | Direct |
| Aug 14, 26 | SCHERER MARY C Officer |
STOCK | 765 | $0 | Direct |
| Aug 14, 26 | WEITZMAN DEBORAH Officer |
STOCK | 7.31K | $0 | Direct |
| Aug 14, 26 | PITTEROFF VALERIE CHRISTINE Officer |
STOCK | 2.98K | $0 | Direct |
| Aug 14, 26 | MAYER JESSICA L. Officer |
STOCK | 6.38K | $0 | Direct |
| Aug 14, 26 | MASON STEPHEN M Officer |
STOCK | 5.87K | $0 | Direct |
| Aug 14, 26 | GREENE MICHELLE D Chief Technology Officer |
STOCK | 2.55K | $0 | Direct |
| Aug 4, 26 | ALT AARON E. Chief Financial Officer |
STOCK | 58.74K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ALT AARON E. |
Chief Financial Officer | 20.50K | Sale |
HALL PATRICIA HEMINGWAY |
Director | 28.64K | Stock Award(Grant) |
HOLLAR JASON M |
Chief Executive Officer | 190.60K | Sale |
JOHRI AKHIL |
Director | 22.87K | Stock Award(Grant) |
KENNY GREGORY B |
Director | 64.19K | Stock Award(Grant) |
KILLEFER NANCY |
Director | 27.62K | Stock Award(Grant) |
MASON STEPHEN M |
Officer | 18.06K | Sale |
MAYER JESSICA L. |
Officer | 62.51K | Stock Award(Grant) |
SNOW OLA M |
Officer | 15.57K | Sale |
WEITZMAN DEBORAH |
Officer | 77.90K | Sale |
Moving averages & technicals
SMA 10
234.15
-2.09% from price
SMA 20
233.60
-1.75% from price
SMA 50
231.68
-0.94% from price
SMA 100
217.01
+5.64% from price
SMA 200
213.92
+7.29% from price
EMA 12
233.06
-1.63% from price
EMA 26
232.22
-1.27% from price
EMA 50
228.40
+0.38% from price
RSI (14)
46.3
Neutral
MACD (12,26,9)
0.84
Hist -0.95
ATR (14)
6.83
2.98% of price
Realised vol 30D
24.0%
Annualised
Bollinger upper
240.96
20, 2σ
Bollinger lower
226.24
20, 2σ
50 / 200 cross
Golden
231.68 vs 213.92
Trend bias
Above 200
+7.29%
Risk profile
Beta vs SPY
-0.09
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
24.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-20.6%
Peak to trough
Max drawdown 5Y
-21.0%
Peak to trough
ATR 14
6.83
2.98% of price
Beta (reported)
0.52
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.60
Call-heavy session
Put / call open interest
1.51
Positioning, not flow
Max pain
232.50
+1.3% from spot
ATM implied vol
29.5%
Nearest strike to spot
Skew (10% OTM)
+13.3%
Puts bid over calls
Call volume
130
Contracts, this expiry
Put volume
78
Contracts, this expiry
Heaviest call OI
235.00
26 contracts
Heaviest put OI
232.50
82 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Cardinal Health CEO Sells $29 Million in Stock After Earnings Send Shares to Record
Barrons.com · 12h ago
Cardinal Health Insider Sold Shares Worth $29,375,516, According to a Recent SEC Filing
MT Newswires · 2d ago
Cardinal Health Insider Sold Shares Worth $8,274,117, According to a Recent SEC Filing
MT Newswires · 2d ago
Cardinal Health Insider Sold Shares Worth $6,952,485, According to a Recent SEC Filing
MT Newswires · 2d ago
Cardinal Health Insider Sold Shares Worth $2,746,187, According to a Recent SEC Filing
MT Newswires · 2d ago
What Is Drawing Attention To Cardinal Health (CAH) Today?
Simply Wall St. · 2d ago
Cardinal Health’s (CAH) Big Earnings Beat Hides a More Complicated Story
Insider Monkey · 3d ago
Cardinal Health's Integration of Higher-Margin Services Will Drive Outperformance, RBC Says
MT Newswires · 3d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.